Casein kinase 1δ/ε inhibition suppresses CLL through cell-intrinsic and microenvironmental mechanisms [RNA-Seq]
RNA-seq (gene expression) · mouse · 42 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Topic
- Chronic lymphocytic leukemiaThis series is part of our curated briefing on it.
- Samples
- 42 samples: 33 distinct titles, 2 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Casein kinase 1δ/ε inhibition suppresses CLL proliferation through cell-intrinsic and microenvironmental mechanismsHemaSphere · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE305855_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1308056 and SRA study SRP610042. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 42 sample titles: 33 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9186228 CLL 1
- GSM9186229 CLL 1, PF-670462
- GSM9186230 CLL 1, M2-10B4
- GSM9186231 CLL 1, M2-10B4, PF-670462
- GSM9186232 CLL 2
- GSM9186233 CLL 2, PF-670462
- GSM9186234 CLL 2, M2-10B4
- GSM9186235 CLL 2, M2-10B4, PF-670462
- GSM9186236 CLL 3
- GSM9186237 CLL 3, PF-670462
- GSM9186238 CLL 3, M2-10B4
- GSM9186239 CLL 3, M2-10B4, PF-670462
- GSM9186240 CLL 4
- GSM9186241 CLL 4, PF-670462
- GSM9186242 CLL 4, M2-10B4
- GSM9186243 CLL 4, M2-10B4, PF-670462
- GSM9186244 CLL 5
- GSM9186245 CLL 5, PF-670462
- GSM9186246 CLL 5, M2-10B4
- GSM9186247 CLL 5, M2-10B4, PF-670462
- GSM9186248 CLL 6
- GSM9186249 CLL 6, PF-670462
- GSM9186250 CLL 6, M2-10B4
- GSM9186251 CLL 6, M2-10B4, PF-670462
- GSM9186252 CLL 7
- GSM9186253 CLL 7, PF-670462
- GSM9186254 CLL 7, M2-10B4
- GSM9186255 CLL 7, M2-10B4, PF-670462
- GSM9186256 CLL 8
- GSM9186257 CLL 8, PF-670462
- GSM9186258 CLL 8, M2-10B4
- GSM9186259 CLL 8, M2-10B4, PF-670462
- GSM9186260 CLL 9
- GSM9186261 CLL 9, PF-670462
- GSM9186262 CLL 9, M2-10B4
- GSM9186263 CLL 9, M2-10B4, PF-670462
- GSM9186264 M2-10B4 1
- GSM9186265 M2-10B4 1, PF-670462
- GSM9186266 M2-10B4 1, C59
- GSM9186267 M2-10B4 2
+ 2 more — browse all 42 samples with per-sample file links →
- GSE313098 Time-series RNA-seq analysis reveals dynamic transcriptional responses and crosstalk in chronic lymphocytic leukaemia (CLL) autologous and monoculture in vitro models 60 samples same disease briefing · shares cll, rna-seq
- GSE277432 Aberrantly Expressed Mitochondrial Lipid Kinase, AGK Activates JAK2-Histone H3 Axis and BCR Signal: A Mechanistic Study with Implication in CLL Therapy 10 samples same disease briefing · shares cll, kinase
- GSE311112 Single-cell RNA-seq analysis reveals distinct tumor and immunosuppressive T-cell phenotypes in CLL patients treated with ibrutinib 105 samples same disease briefing · shares cll, rna-seq
- GSE249956 Trascriptional profiling of proliferating and resting fracntions in ibrutinib-treated CLL 40 samples same disease briefing · shares cll
- GSE319429 Defining the acute BTK-loss transcriptional program in CLL using a BTK degrader 32 samples same disease briefing · shares cll
- GSE293100 Modulation of NOTCH1 signaling in CLL and MCL cell lines 30 samples same disease briefing · shares cll
- GSE329311 B cell receptor-mediated amplification of the interferon response in CLL cells 12 samples same disease briefing · shares cll
- GSE252613 PD-1 expression contributes to the functional impairment of NK cells in patients with B-CLL 4 samples same disease briefing · shares cll
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.